Literature DB >> 2952590

Atrial natriuretic factor inhibits central angiotensin II pressor responses.

R Casto, J Hilbig, G Schroeder, G Stock.   

Abstract

Intracerebroventricular (i.c.v.) administration of human atrial natriuretic factor (ANF), fragment 1-25, in the dose range 3 to 20 micrograms/kg did not alter resting arterial pressure or heart rate in rats anesthetized with chloralose/urethan (60:600 mg/kg i.p.), while angiotensin II (ANG II), 1 microgram/kg, produced a significant increase in arterial pressure after i.c.v. application. This pressor effect induced by ANG II was abolished by simultaneous administration of ANF (3 micrograms/kg i.c.v.). In isolated strips of rabbit aorta preconstricted with ANG II (10 nM), ANF caused a dose-dependent relaxation. In intact rats, the increase in blood pressure following intravenously administered ANG II (0.1 and 1 microgram/kg) was not altered by the highest dose of ANF (20 micrograms/kg) given intracerebroventricularly. These results suggest that atrial peptides may play an important role in the regulation of blood pressure by interacting with both the central and peripheral actions of ANG II. Inhibition of the central pressor action of angiotensin by ANF appears to be independent of any direct peripheral effect of the atrial peptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952590     DOI: 10.1161/01.hyp.9.5.473

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

2.  Atrial natriuretic peptide regulation of noradrenaline release in the anterior hypothalamic area of spontaneously hypertensive rats.

Authors:  N Peng; S Oparil; Q C Meng; J M Wyss
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; M Apostolakis; S Bountzioukas; O Guiba-Tziampiri; H Kontoleon-Vakalopoulou; K Mavroudis
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

4.  Blockade of endogenous anterior hypothalamic atrial natriuretic peptide with monoclonal antibody lowers blood pressure in spontaneously hypertensive rats.

Authors:  R H Yang; H K Jin; Y F Chen; J M Wyss; S Oparil
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 5.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

6.  Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats.

Authors:  Katsunori Isa; Maria Antonia García-Espinosa; Amy C Arnold; Nancy T Pirro; Ellen N Tommasi; Detlev Ganten; Mark C Chappell; Carlos M Ferrario; Debra I Diz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-29       Impact factor: 3.619

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.